Building “Off-the-Shelf” Regenerative Cell Therapies: The Next Biotech Revolution | Brian Culley - CEO, Lineage Cell Therapeutics

Episode notes

Send us Fan Mail Today’s conversation sits at the intersection of one of the most ambitious - and most challenging - frontiers in modern medicine: regenerative cell therapy. For decades, the vision has been incredibly compelling - replace damaged or dying cells with healthy ones, and you could potentially restore function in diseases like macular degeneration, spinal cord injury, hearing loss, and even Type 1 diabetes. But while the science has advanced, the field has consistently run into a different kind of barrier: how do you actually manufacture living cells as consistent, scalable, affordable therapies? That’s not just a biology problem - it’s an engineering, manufacturing, and business problem. And it’s one that today’s guest has spent his entire career navigating. Brian Culley brings more than three decades of experience across the life sciences industry, spanning drug development, business development, and executive leadership.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on Biotech81 / 100
• The Frontier State of Nonprofit AcceleratorsThe Frontier State Podcast · on Biotech78 / 100
• Leading your cross-disciplinary team, with Dr. Marinna Madrid of Cellino From Founder to Leader · on regenerative medicine74 / 100
• Deep Tech Gold Rush: Smart Boom or Future Bust?Venture Unlocked · on Biotech71 / 100
• #113 - What was Fred Hoch from TechNexus doing in his 20sinTheir20s · on Biotech57 / 100
• TFS#260 - Sebastian Siegel: The Truth About AI, Exosomes & Human Consciousness THE FLIP SIDE with Andy Mai · on Stem cells52 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100
• How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 100
• 55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100
• How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences